Vincristine attenuates doxorubicin cardiotoxicity
- 5 September 2008
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 373 (4), 555-560
- https://doi.org/10.1016/j.bbrc.2008.06.067
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stressJournal of Molecular and Cellular Cardiology, 2007
- Doxorubicin-Induced Cardiomyopathy: From the Cardiotoxic Mechanisms to ManagementProgress in Cardiovascular Diseases, 2007
- Multiple actions of pifithrin-α on doxorubicin-induced apoptosis in rat myoblastic H9c2 cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Preventive Effect of Erythropoietin on Cardiac Dysfunction in Doxorubicin-Induced CardiomyopathyCirculation, 2006
- Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicityToxicology and Applied Pharmacology, 2004
- An Automated HPLC Method to Determine Intracellular Vincristine Concentrations in Mononuclear Cells of Children with Acute Lymphoblastic LeukemiaTherapeutic Drug Monitoring, 2003
- Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats.Free Radical Research, 2001
- The anthracyclines: will we ever find a better doxorubicin?1992
- Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancerCancer Chemotherapy and Pharmacology, 1990